EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacomechanical Thrombectomy and Catheter-Directed Thrombolysis, with or without Iliac Vein Stenting, in the Treatment of Acute Iliofemoral Deep Vein Thrombosis

Pharmakomechanische Thrombektomie und kathetergerichtete Thrombolyse mit oder ohne Iliakalvenen-Stent bei akuter iliofemoraler tiefer Venenthrombose

Evren Ozcinar iD, Nur Dikmen iD, Ahmet Kayan iD, Melisa Kandemir iD, Mehmet Cahit Saricaoglu iD

Journal of Cardiovascular Development and Disease · 09.07.2024 · 11 (7) · 214

DOI: 10.3390/jcdd11070214 ↗

Auf einen Blick

Bei 112 Patient:innen mit akuter iliofemoraler TVT wurden PMCT+CDT und PMCT+CDT+Stent verglichen. Die Offenheitsraten und PTS-Raten unterschieden sich nicht signifikant.

Fragestellung

Unterscheiden sich PMCT+CDT und PMCT+CDT+Stent bei akuter iliofemoraler tiefer Venenthrombose hinsichtlich Offenheit, PTS und Sicherheit?

Methode

Retrospektive Fall-Kontroll-Studie über 3 Jahre mit 112 Patient:innen; Nachbeobachtung 24 Monate; Vergleich von PMCT+CDT mit PMCT+CDT+venösem Stent.

Ergebnisse

63 Patient:innen erhielten PMCT+CDT, 49 PMCT+CDT+Stent. 6-Monats-Patency 82,5 % vs. 81,6 %; 2-Jahres-Patency 85,7 % vs. 83,7 %. PTS nach 24 Monaten 11,1 % vs. 22 % (p = 0,381).

Schlussfolgerung der Autor:innen

PMCT+CDT war wirksam zur Linderung von Beinsymptomen und zur Senkung von PTS, einschließlich moderat bis schwerer PTS. PMCT+CDT+Stent könnte die langfristige venöse Offenheit und die Lebensqualität verbessern.

Kernaussagen

  • 6-Monats-Patency: 82,5 % vs. 81,6 %
  • PTS nach 24 Monaten: 11,1 % vs. 22 %
  • Blutungsereignisse traten in beiden Gruppen auf

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 09.07.2024. Verfasst von Evren Ozcinar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, Ankara 06230, Turkey. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aims to evaluate and compare the outcomes and clinical efficacy of pharmacomechanical thrombectomy (PMCT) plus catheter-directed thrombolysis (CDT) and PMCT combined with CDT and venous stenting in managing acute iliofemoral deep vein thrombosis (DVT), while also assessing the long-term safety and efficacy of these interventions.

Methods

A retrospective case–control study spanning 3 years involved 112 patients presenting with acute symptomatic iliofemoral deep vein thrombosis (DVT), each with a symptom duration of less than 14 days. Patients were consecutively categorized into two groups based on individual clinical indications: PMCT + CDT vs. PMCT + CDT + venous stent. Statistical analyses were conducted to compare clinical features and outcomes between the two groups. Additionally, patients were followed up for 24 months post-treatment, during which quality of life (QoL) and severity of post-thrombotic syndrome (PTS) were analyzed.

Results

In this retrospective study, we analyzed a total of 112 consecutive patients, with 63 patients undergoing PMCT + CDT and 49 patients undergoing PMCT + CDT + venous stent. Between the two groups, regarding primary outcomes at 6 months, there was no difference in the observed cumulative patency rates, standing at 82.5% for PMCT + CDT and 81.6% for PMCT + CDT + stent. Survival analyses for primary, primary-assisted, and secondary patency yielded comparable results for PMCT + CDT, with p-values of 0.74, 0.58, and 0.72, respectively. The two-year patency rate was high in both groups (85.7% for PMCT + CDT vs. 83.7% for PMCT + CDT + stent). Additionally, during the follow-up period, there were no statistically significant differences observed in the incidence of PTS or the average Villalta score between the two groups. At 24 months post-intervention, the incidence of post-thrombotic syndrome (PTS) was 11.1% in the PMCT + CDT group and 22% in the PMCT + CDT + stent group (p = 0.381). Both treatment arms of the study groups experienced bleeding complications during the thrombolysis therapy; in the PMCT + CDT group, there were three cases of gastrointestinal bleeding, compared to two cases in the PMCT + CDT + stent group (p = 0.900). Additionally, there was one intracranial hemorrhage in the PMCT + CDT group and two in the PMCT + CDT + stent group.

Conclusions

Pharmacomechanical thrombectomy (PMCT) combined with catheter-directed thrombolysis (CDT) therapy has shown significant efficacy in alleviating leg symptoms and reducing the occurrence of post-thrombotic syndrome (PTS), including the incidence of moderate-to-severe PTS. On the other hand, the utilization of PMCT + CDT + stent therapy, tailored to individual patients’ clinical and venous conditions, may enhance long-term venous patency and lead to superior outcomes, including improved quality of life parameters.

Schlagwörter

Stichwörter der Autor:innen

acute deep vein thrombosiscatheter-directed thrombolyticendovascular procedurespharmacomechanical thrombectomyvenous stent

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, Ankara 06230, Turkey.
  • Department of Cardiovascular Surgery, Kirikkale High Specialization Hospital, Kirikkale 71300, Turkey.

ORCID-Profile: Evren Ozcinar, Nur Dikmen, Ahmet Kayan, Melisa Kandemir, Mehmet Cahit Saricaoglu

Zitieren

APA

Ozcinar, E., Dikmen, N., Kayan, A., Kandemir, M., & Saricaoglu, M. C. (2024). Pharmacomechanical Thrombectomy and Catheter-Directed Thrombolysis, with or without Iliac Vein Stenting, in the Treatment of Acute Iliofemoral Deep Vein Thrombosis. Journal of Cardiovascular Development and Disease, 11(7), 214. https://doi.org/10.3390/jcdd11070214

Vancouver

Ozcinar E, Dikmen N, Kayan A, Kandemir M, Saricaoglu MC. Pharmacomechanical Thrombectomy and Catheter-Directed Thrombolysis, with or without Iliac Vein Stenting, in the Treatment of Acute Iliofemoral Deep Vein Thrombosis. Journal of Cardiovascular Development and Disease. 2024;11(7):214. doi:10.3390/jcdd11070214

BibTeX
@article{Ozcinar2024,
  author = {Ozcinar, Evren and Dikmen, Nur and Kayan, Ahmet and Kandemir, Melisa and Saricaoglu, Mehmet Cahit},
  title = {Pharmacomechanical Thrombectomy and Catheter-Directed Thrombolysis, with or without Iliac Vein Stenting, in the Treatment of Acute Iliofemoral Deep Vein Thrombosis},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2024},
  volume = {11},
  number = {7},
  pages = {214},
  doi = {10.3390/jcdd11070214}
}
Kostenlos starten →